admin – Page 11 – Swanson Reed | Specialist R&D Tax Advisors

SelSym Biotech’s Breakthrough: Synthetic Platelets to Control Bleeding

SelSym Biotech, a startup pioneering in biotechnology, is on a mission to transform hemostasis with its groundbreaking development of synthetic platelets. Traditional platelets, essential for clotting and stopping bleeding, are in perpetual short supply due to their short shelf life. Recognizing this critical challenge, SelSym Biotech has unveiled a revolutionary solution: synthetic platelets.

Led by Ashley Brown, Ph.D., a biomedical engineer at North Carolina State University (NCSU), SelSym Biotech’s research team has developed tiny bits of ultra-soft hydrogel, termed platelet-like particles (PLPs), equipped with antibodies that bind directly to fibrin, a protein found at the wound site. These PLPs mimic the function of natural platelets, effectively stopping bleeding when they come into contact with fibrin.

The potential of SelSym’s synthetic platelets extends beyond addressing donor shortages. Unlike natural platelets, which have a short shelf life and require specific storage conditions, PLPs offer a longer shelf life and can be stored at room temperature, making them easier to transport and distribute, especially in remote or challenging-to-reach locations.

SelSym’s approach minimizes the risk of off-target blood clot formation, ensuring safety and efficacy in clinical applications. Promising results from studies conducted in mice, rats, and pigs demonstrate the effectiveness of PLPs in stopping trauma-induced bleeding without adverse effects.

With support from grants and ongoing research collaborations, SelSym Biotech is advancing towards clinical trials, aiming to translate its innovative technology into practical solutions for preventing unnecessary deaths due to uncontrolled bleeding.

SelSym Biotech’s journey exemplifies a commitment to overcoming critical challenges in medicine, offering hope for improved clinical outcomes and transforming the landscape of hemostasis with synthetic platelets.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Fueling the Future: Terragia’s Innovative Biofuel Technology

Terragia Biofuel Incorporated, a pioneering cleantech startup, recently announced the successful closure of its seed financing round, securing an impressive $6 million. This significant capital injection is aimed at advancing the company’s innovative approach to converting biomass into ethanol and various sustainable products, driving its growth and facilitating commercialization.

Founded in 2022 and headquartered in New Hampshire, Terragia specializes in cutting-edge technology aimed at producing sustainable fuels derived from cellulosic biomass. What sets Terragia apart is its unique biology-centric approach, which harnesses thermophilic microorganisms to seamlessly convert biomass into ethanol, bypassing the need for enzymatic additives and thermochemical pretreatment.

This groundbreaking methodology not only mitigates significant cost overheads typically associated with conventional cellulosic biofuel production but also caters to the fuel requirements of challenging-to-electrify transportation sectors like aviation, ocean shipping, and long-haul trucking.

The recent funding round, led by Engine Ventures and Energy Impact Partners, reflects growing optimism about Terragia’s potential to thrive in the cellulosic biofuel sector. Terragia’s vision for sustainable fuel solutions holds immense potential to revolutionize the biofuel industry and drive meaningful progress towards a greener, more sustainable future.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Driving Change: Yoshi Mobility Diversifies with Series C Investment Boost

Yoshi Inc. (Yoshi Mobility), a tech-enabled mobile car care company, has marked a significant milestone with the closure of its $26 million Series C funding round. This round, which includes strategic investments from heavyweights like General Motors Ventures and Bridgestone Americas, as well as international backers Universal Motors Agencies and Shikra Limited, signals a new chapter of growth and innovation for the company.

Emerging from Y Combinator in 2016, Yoshi Mobility has rapidly garnered attention and investment, with previous support from notable names like ExxonMobil, DN Automotive, NBA star Kevin Durant, and NFL legend Joe Montana. With this latest infusion of capital, totaling over $60 million to date, Yoshi Mobility is poised to accelerate its expansion and solidify its position as a leader in the mobile car care industry.

In response to the shifting landscape catalyzed by the pandemic, Yoshi Mobility has experienced exponential revenue growth, driven by its fleet business and strategic partnerships with Fortune 100 companies. Building on this momentum, the Series C funding round enables Yoshi Mobility to diversify its offerings and venture into three new business lines: preventative maintenance, virtual vehicle inspections, and electric vehicle (EV) charging.

A key milestone in this diversification journey is Yoshi Mobility’s recent acquisition of Mobile Auto Concepts Inc. (MACi), a mobile automotive services company specializing in preventative maintenance, tire care, and more. Additionally, Yoshi Mobility is spearheading innovation in the EV charging space, leveraging its platform and technology stack to provide on-the-go charging, maintenance, and support for EV owners and enterprise customers.

With millions of vehicle services completed and a commitment to making car ownership seamless and efficient, Yoshi Mobility is driving towards a future where mobility is frictionless and customers are empowered to keep moving safely and sustainably. As the automotive landscape continues to evolve, Yoshi Mobility stands ready to meet the needs of a rapidly changing market and lead the charge towards a more connected and convenient automotive experience.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Catalyzing Growth: StartUp Hutch and K-State 105 Join Forces for Economic Development

IN3 Announces David Beering as VP of Hypersonics

StartUp Hutch and K-State 105 have joined hands in a strategic alliance aimed at catalyzing economic development in Hutchinson and beyond. This partnership signals a concerted effort to invigorate Reno County’s economy by nurturing local start-ups and entrepreneurs.

Through this collaboration, both entities pledge to provide comprehensive support to emerging businesses, ranging from funding assistance to mentorship programs. The goal is to create a thriving ecosystem where entrepreneurs can flourish and contribute to job creation and economic prosperity.

Central to this initiative is the introduction of an Entrepreneur Navigator (E-Navigator) who will serve as a guide for local entrepreneurs, facilitating cooperative efforts and building crucial relationships. Jessica Gnad, Director of K-State 105, envisions this initiative as a catalyst for innovation across all 105 counties, fostering a vibrant entrepreneurial spirit.

K-State 105 is committed to offering resources and tools to empower small businesses and entrepreneurs. Workshops and mentoring sessions are planned to aid business development and expansion, further fueling local economic growth.

To ensure the success of this partnership, solid relationships with local leaders and stakeholders are paramount. Executive Director of StartUp Hutch, Jackson Swearer, believes that fostering entrepreneurship will not only bolster the local economy but also promote community development and improve living standards.

In addition to StartUp Hutch and K-State 105, other organizations like NetWork Kansas, Hutchinson Community College, and K-State Research and Extension will play integral roles in fostering an environment conducive to entrepreneurial success. Together, they aim to replicate successful models statewide, stimulating economic development across Kansas.

This collaboration represents a concerted effort to fortify Reno County’s economy, fostering a culture of innovation and adaptability essential for sustainable economic resilience and prosperity in the region.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Fueling Innovation: iVEAcare Raises $27.5M to Advance Neuromodulation Therapy

iVEAcare, Inc., a pioneer in neuromodulation technology, has announced the successful close of a $27.5 million Series A financing round. Led by Vensana Capital, with participation from Treo Ventures, Hatteras Venture Partners, and an undisclosed strategic partner, this funding marks a significant milestone for the Minneapolis-based medical device company.

The company, the third spin-off from NuXcel, a renowned medical device accelerator, is dedicated to developing and commercializing next-generation neuromodulation technologies for treating chronic diseases. With this substantial investment, iVEAcare aims to propel its innovative neuromodulation therapy into the forefront of medical advancement.

Alongside the funding announcement, iVEAcare has appointed Todd Kerkow as President and CEO. With nearly three decades of experience in the medical device industry, including stints at Guidant, Cameron Health, Boston Scientific, and Cardionomic, Kerkow brings a wealth of expertise to lead the company forward.

Expressing excitement about the future, Kerkow emphasized the importance of the experienced investor group supporting iVEAcare. He envisions this Series A financing as a pivotal step towards delivering innovative neuromodulation therapy to patients and clinicians alike.

Amrinder Singh and Kirk Nielsen of Vensana Capital echoed Kerkow’s sentiments, highlighting the significance of neuromodulation as a frontier in medicine. They see iVEAcare’s technology as a potential best-in-class therapy with the power to impact countless patients positively.

With strong support from seasoned investors and a dedicated team at the helm, iVEAcare is poised to revolutionize neuromodulation therapy and make significant strides in improving patient outcomes.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Breaking Barriers: Casa Shares Raises $1.5M to Democratize Real Estate Investing

Casa Shares, a real estate investing platform, has raised $1.5 million in pre-seed funding, marking a significant step towards democratizing real estate investment. Founded by Mirza Beg and McKay Francis, Casa Shares simplifies the investment process, allowing users to acquire shares in prime income properties starting at just $100.

The platform addresses a pressing issue: the exclusion of younger generations from real estate wealth-building due to soaring property prices. Casa Shares aims to break down these barriers, offering an inclusive investment experience accessible to all.

In today’s volatile market, the search for stable investment options has intensified. Real estate emerges as a desirable alternative, yet high entry costs deter many potential investors, particularly first-timers.

Casa Shares is committed to democratizing real estate investment, making it feasible for millions without the necessary funds, time, or expertise to venture into property investment independently.

With their first offering, The Lorene, a premium condominium in Rexburg, Idaho, Casa Shares has already made strides towards their mission. Looking ahead, the company plans to diversify its portfolio with properties in various locations and is developing an iOS app to enhance the investment experience.

The funding round, led by private investors sharing Casa Shares’ vision, underscores the importance of creating an inclusive real estate investing ecosystem for future generations.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

EarliTec Diagnostics Secures $21.5M for Groundbreaking Autism Diagnostic Tool

In a groundbreaking development for autism diagnostics, EarliTec Diagnostics, Inc. has secured $21.5 million in Series B financing. Led by Nexus NeuroTech Ventures and Venture Investors Health Fund, this funding will propel the commercialization of the EarliPoint Evaluation and drive further product development efforts.

EarliTec’s EarliPoint Evaluation is a first-of-its-kind tool designed to assist clinicians in diagnosing and assessing autism in toddlers aged 16-to-30 months. Utilizing Social-Visual Engagement technology, it tracks a child’s moment-by-moment looking behavior, providing objective measurements crucial for early identification of autism.

Despite autism’s prevalence, limited access to diagnosis and treatment options poses challenges for families. EarliPoint addresses this gap by offering a personalized, quantifiable, and objective diagnostic tool, empowering clinicians to deliver timely and personalized care.

The Series B funding will further EarliTec’s mission to expand EarliPoint’s commercialization efforts and complete studies validating its efficacy for children up to seven years old. With continued investment and innovation, EarliTec is poised to transform the landscape of childhood diagnostics, ensuring that every child receives the support they need, when it matters most.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Upstage’s $72M Series B Funding Marks Milestone in AI Innovation

Upstage Co., Ltd., the South Korean AI powerhouse, is making waves in the tech world once again. With a recent $72 million injection in its Series B funding round, the company’s total investment now exceeds $100 million, solidifying its position as a trailblazer in AI software development.

Led by CEO Sung Kim, Upstage is on a mission to revolutionize work efficiency with its cutting-edge AI solutions. Their flagship product, Solar LLM, has garnered praise for its lightning-fast performance and unmatched cost-efficiency. By leveraging Depth-Up Scaling (DUS) technology, Solar delivers GPT-4-level performance, catering to the diverse needs of businesses across various industries.

But Upstage isn’t stopping there. The company’s Document AI solution, powered by state-of-the-art OCR technology, is transforming document processing for high-growth sectors like finance and healthcare. With clients including industry giants like Samsung and Hanwha, Upstage’s Document AI is streamlining workflows and reducing operational costs for businesses worldwide.

The Series B funding will fuel Upstage’s ambitious plans for global expansion, including the establishment of a new office in San Jose, California. This strategic move will enable Upstage to accelerate the development of purpose-trained LLMs tailored to the needs of global enterprises.

Leading the investment round are prominent backers such as SK Networks, KT, and Korea Development Bank, reaffirming their confidence in Upstage’s vision and capabilities. Existing investors, including SBVA and Primer Sazze Partners, have also doubled down on their support, recognizing Upstage’s potential to reshape the future of AI.

Founded in 2020, Upstage is committed to enhancing work efficiency through industry-leading document processing engines and LLMs. With Solar LLM and Document AI at the forefront of innovation, Upstage is poised to lead the AI revolution, one breakthrough at a time.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

dataplor Raises $10.6M Series A to Expand Global Location Intelligence

dataplor, a leading provider of global location intelligence solutions, has announced a successful Series A funding round. The round resulted in $10.6 million and was led by Spark Capital. This strategic investment underscores dataplor’s commitment to advancing its position as a premier source of international location data for enterprises worldwide.

With a vast database comprising over 300 million places across more than 200 countries and territories, dataplor stands at the forefront of delivering accurate and comprehensive location insights to businesses across various industries. From technology and logistics to consumer goods and finance, organizations rely on dataplor’s global coverage to drive informed decision-making and navigate complex market landscapes.

This funding round enables dataplor to further expand its worldwide coverage and enhance its suite of location intelligence solutions. By investing in product development and innovation, dataplor aims to provide its customers with even more robust and actionable insights to support their growth and expansion strategies.

dataplor’s innovative approach combines advanced technologies such as artificial intelligence and machine learning with a robust global infrastructure to gather, validate, and deliver location data with unparalleled precision. This ensures that customers receive timely and reliable information to support their expansion initiatives and strategic planning efforts.

In addition to enhancing its data coverage and product offerings, dataplor remains committed to maintaining the highest standards of data privacy and security. By adhering to ethical practices and stringent data protection measures, dataplor ensures that customers can leverage its solutions with confidence and trust.

As dataplor embarks on its next phase of growth and expansion, fueled by the Series A funding, it remains steadfast in its mission to empower businesses with actionable location intelligence, enabling them to unlock new opportunities and drive success on a global scale.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Nectar’s Sweet Success: Securing $40 Million Series B Funding

PerkCity, Inc. (DBA Nectar), the Utah-based culture platform specializing in employee recognition and rewards, has reached a significant milestone with the announcement of a committed $40 million Series B Funding Round. This funding, led by PeakSpan Capital, represents a pivotal moment for Nectar as it embarks on a journey of growth and expansion.

With this substantial investment, Nectar is poised to accelerate the development of its platform and suite of product services, focusing on enhancing workplace culture through recognition. The infusion of capital will enable Nectar to further innovate its core recognition products and introduce new strategic offerings designed to support organizations in building strong and engaged workplace cultures.

The Series B raise underscores Nectar’s commitment to empowering organizations worldwide to cultivate vibrant and inclusive environments where every individual feels valued and appreciated. By investing in research and development, Nectar aims to remain at the forefront of the industry, delivering impactful solutions to its growing client base.

The partnership with PeakSpan Capital provides Nectar with valuable resources and expertise to fuel its growth trajectory. With a focus on scalability, user experience, and innovation, Nectar is well-positioned to drive meaningful change in the workplace culture space.

The announcement of the Series B Funding marks a new chapter for Nectar, signaling its commitment to driving positive change in workplace culture worldwide. With a focus on innovation and growth, Nectar is poised to make a lasting impact on organizations and employees alike, shaping the future of work for years to come.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.